SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-028697
Filing Date
2022-05-12
Accepted
2022-05-12 20:26:35
Documents
1
Period of Report
2022-05-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5761
  Complete submission text file 0001209191-22-028697.txt   7323
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Issuer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 740 BROADWAY 9TH FLOOR NEW YORK NY 10003
Business Address
Meckler Jeffrey A (Reporting) CIK: 0001506916 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36257 | Film No.: 22919773